By Sharon AtienoKenya will introduce Lenacapavir, a twice-yearly injectable pre-exposure prophylaxis (PrEP), in January 2026.The priority will be given to 10 counties, including Nairobi, Kajiado, ...
Encouraging the use of pre-exposure prophylaxis (PrEP) depends on the way that HIV risk is communicated to subgroups that are traditionally at the highest risk. A new study found that interest in PrEP ...